Contact Us: 734-712-3456
Media Contact:
Laura Blodgett, Media Relations
Saint Joseph Mercy Health System

Aronow Named Next Governor of ACC Michigan Chapter
Start Date
Dr. Herb Aronow named next Governor of the Michigan Chapter of the American College of Cardiology

Herb Aronow, M.D., MPH, a cardiologist at Michigan Heart of St. Joseph Mercy Ann Arbor, has been elected as the next Michigan governor to the American College of Cardiology (ACC). He will serve as governor-elect for a one-year period beginning March 2013 and then assume the three-year governorship in March 2014. In that capacity, he will concurrently serve as president of the Michigan chapter of the ACC.

“We are currently witnessing a sea change within the U.S. health care system and the cardiovascular arena is no exception,” said Dr. Aronow. “Despite the uncertainty, I hope to build on our innovative quality initiatives, successful educational endeavors and well-organized advocacy efforts to ensure that cardiovascular patients continue to have access to high-quality, appropriate and cost-effective care.”

As president of the Michigan chapter, Dr. Aronow hopes to develop a shared cardiovascular educational platform to be used across Michigan’s medical institutions. He also will work to support national ACC advocacy efforts in delivery system, imaging, physician payment and FDA reform, and seeking greater funding for cardiovascular disease prevention and research efforts.

“We are very proud to have one of our top cardiologists elected to this distinguished group of the nation’s leading cardiologists,” said Rob Casalou, president and CEO, St. Joseph Mercy Ann Arbor and Livingston. “We congratulate Dr. Aronow on this prestigious appointment.”

Dr. Aronow is interim medical director of the cardiac catheterization laboratory at St. Joseph Mercy Ann Arbor and director of the Michigan Heart Comprehensive Vascular Program. He is a member of the hospital’s Cardiovascular Quality Steering, Cardiovascular Operations, Research and multidisciplinary Vascular Steering committees. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

Dr. Aronow attended the University of Michigan for his undergraduate studies, medical school, internal medicine residency and master's degree in public health. He completed both general and interventional cardiovascular medicine fellowships at the Cleveland Clinic, after which he joined the faculty at the University of Pennsylvania as an assistant professor. At Penn, he directed both the peripheral vascular intervention program at the hospital of the University of Pennsylvania and the cardiac catheterization laboratory at the Philadelphia VA Medical Center.

A member of the ACC since 1998, Dr. Aronow chaired the Michigan chapter’s Vascular Update at the Michigan State Medical Society Annual Scientific Meeting from 2006-2010. He also served as an ACC representative to the Michigan Department of Community Health Certificate of Need Commission Standard Advisory Committee for Cardiac Catheterization in 2007, and has been a member of the chapter’s Interventional Cardiology Expert Standby Panel since 2008. Dr. Aronow was elected to the Michigan ACC Chapter Council in 2010, and served on its nominating committee in 2011. He chaired the chapter’s Cardiovascular Summit in 2011, co-chaired the 2012 summit and is on the planning committee for the 25th anniversary summit in 2013.

At a national level, Dr. Aronow served on the ACC Peripheral Vascular Disease (PVD) Committee from 2009-2012 and has begun a second term as chair of that committee. He also serves on the ACC Interventional Scientific Council as its PVD committee representative. Dr. Aronow is on the faculty for the ACC and TCT@ACC Annual Scientific Sessions, and is on the planning committee and Endovascular Working Group for TCT@ACC.13. He is a reviewer for the ACC journals JACC and JACC: Cardiovascular Interventions.

In addition to his work with ACC, Dr. Aronow also serves as a trustee of the Society for Vascular Medicine, and on the Early Career Development Committee in the Society for Cardiovascular Angiography and Interventions.

# # #